News
10h
MedPage Today on MSNDrug Used by Trump Has Suicide Risk; FDA's 'Aggressive' AI Rollout; 1K Measles CasesThoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), the European Medicines Agency (EMA) ...
The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...
The European drugs regulator said on Thursday its safety panel has confirmed suicidal thoughts as a side effect of ...
U.S. and European health regulators are warning the public of possible health risks linked to finasteride, a popular hair-loss drug.
The inspection was conducted by the Finnish Medicines Agency on behalf of EMA from March 10 to March 14 and it concluded with ...
12h
Pharmaceutical Technology on MSNBavarian Nordic shares rise 7% following strong Q1 for vaccine salesBavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...
14h
GlobalData on MSNGSK reports results from trial of IBAT inhibitor for itch in PBC patientsGSK has reported positive outcomes from the Phase III GLISTEN trial of linerixibat for cholestatic pruritus (itch) and PBC.
We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to ...
Morningstar brands and products Company Portfolio ...
1d
MedPage Today on MSNWho Is Trump's Surgeon General Pick? Drug Cost Executive Order; Combo Flu-COVID VaxColumbia University and NewYork-Presbyterian Hospital agreed to pay $750 million to settle hundreds of sexual abuse claims ...
Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA).
The EMA has recommended extensions to the marketing authorizations for Adcetris, used to treat Hodgkin lymphoma, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results